(VIANEWS) - NextEra Energy Partners, LP (NEP), Canadian Natural Resources Limited (CNQ), Digital Ally (DGLY) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. NextEra Energy Partners, LP (NEP)
58.7% sales growth and 9.01% return on equity
NextEra Energy Partners, LP, acquires and owns clean energy projects throughout the United States. The company owns an array of renewable energy assets, including solar and wind projects. It also has natural gas pipeline assets. It was established in Juno Beach in Florida in 2014.
NextEra Energy Partners, LP's sales growth this year is anticipated to be 41.3% and 10.5% for next year.
Year-on-year quarterly revenue growth grew by 43.1%, now sitting on 1.13B for the twelve trailing months.
Volume
Today's last reported volume for NextEra Energy Partners, LP is 263284 which is 49.16% below its average volume of 517900.
NextEra Energy Partners, LP's sales growth for the next quarter is 58.7%. The company's growth estimates for the current quarter and the next is 150% and 466.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.01%.
Volatility
NextEra Energy Partners, LP's last day, last week, and last month's current intraday variation average was 1.96%, 0.98%, and 1.04%, respectively.
NextEra Energy Partners, LP's highest amplitude of average volatility was 3.06% (day), 1.87% (last week), and 1.98% (last month), respectively.
NextEra Energy Partners, LP's Stock Yearly Top and Bottom Value
NextEra Energy Partners, LP's stock is valued at $83.29 at 16:22 EST, below its 52-week high of $88.80 and way above its 52-week low of $61.31.
NextEra Energy Partners, LP's Moving Average
NextEra Energy Partners, LP's value is above its 50-day moving average of $78.36 and above its 200-day moving average of $77.37.2. Canadian Natural Resources Limited (CNQ)
41.1% sales growth and 26.18% return on equity
Canadian Natural Resources Limited is a company that acquires, investigates for, develops and produces crude oil and natural gas as well as natural gas liquids. It offers synthetic crude oil (SCO), medium and light crude oils, as well as Pelican Lake high-grade crude oil. Two crude oil pipelines are among its midstream assets. It also owns a working interest of Primrose's 84-megawatt cogeneration facility. The company's total proven crude oil, bitumen and NGLs resources were 10,528,000,000 barrels (MMbbl). It also had proved SCO reserves of 6,998MMbbl. Proved SCO reserves totaled 7,535MMbbl. Total proved plus probable reserves for SCO were 7,535MMbbl. They also have total proved and probable reserves of 7,535MMbbl. As well as proved natural gas reserves, 12,168 Bcf. and 20,249Bcf. The company's primary operations are in Western Canada, the United Kingdom section of the North Sea and Offshore Africa. It was formerly called AEX Minerals Corporation. In December 1975, Canadian Natural Resources Limited became its new name. Canadian Natural Resources Limited was established in 1973. It is located in Calgary, Canada.
Canadian Natural Resources Limited's sales growth this year is expected to be 41.7% and a negative 17.4% for next year.
Year-on-year quarterly revenue growth grew by 61.6%, now sitting on 34.13B for the twelve trailing months.
Volume
Today's last reported volume for Canadian Natural Resources Limited is 1569880 which is 50.73% below its average volume of 3186380.
Canadian Natural Resources Limited's sales growth is a negative 0% for the ongoing quarter and 41.1% for the next. The company's growth estimates for the ongoing quarter and the next is 132% and 102.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.18%.
Volatility
Canadian Natural Resources Limited's last day, last week, and last month's current intraday variation average was 2.02%, 2.26%, and 1.83%, respectively.
Canadian Natural Resources Limited's highest amplitude of average volatility was 2.29% (day), 2.98% (last week), and 2.88% (last month), respectively.
Canadian Natural Resources Limited's Stock Yearly Top and Bottom Value
Canadian Natural Resources Limited's stock is valued at $55.02 at 16:22 EST, way below its 52-week high of $69.15 and way above its 52-week low of $31.06.
Canadian Natural Resources Limited's Moving Average
Canadian Natural Resources Limited's value is higher than its 50-day moving average of $51.99 and above its 200-day moving average of $53.29.3. Digital Ally (DGLY)
22.6% sales growth and 3.94% return on equity
Digital Ally, Inc. manufactures and sells safety products and digital video storage, disinfectant, and other related safety products, for law enforcement, security, commercial, and international applications. In-car digital mirror systems are available for law enforcement. There is also a commercial fleet-specific in-car system for recording digital events. The website offers a range of tools and data management software to help fleet managers organize, archive, manage, and manage videos and other telematics information. VuLink, which allows an in car digital audio/video system as well as a body-worn digital audio/video cam system, to simultaneously record and start automatically, can be found in every vehicle. It also provides VuVault.net, a law enforcement cloud storage solution; FleetVU Manager, a web-based software for commercial fleet tracking and monitoring; ThermoVu, a non-contact temperature-screening instrument that measures temperature through the wrist and controls entry to facilities when temperature measurements exceed pre-determined parameters; and shield disinfectants and cleansers, as well as other personal protective equipment and supplies, such as masks and gloves to health care workers and other consumers. It sells products via direct sales as well as through third-party distributors. Digital Ally, Inc., is located in Lenexa, Kansas.
Digital Ally's sales growth this year is anticipated to be 122.1% and 16.2% for next year.
Year-on-year quarterly revenue growth grew by 275%, now sitting on 36.03M for the twelve trailing months.
Volume
Today's last reported volume for Digital Ally is 415779 which is 16.6% above its average volume of 356565.
Digital Ally's sales growth is a negative 0% for the current quarter and 22.6% for the next. The company's growth estimates for the current quarter and the next is a negative 168.8% and negative -1000%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.94%.
Volatility
Digital Ally's last day, last week, and last month's current intraday variation average was 1.67%, 4.35%, and 3.29%, respectively.
Digital Ally's highest amplitude of average volatility was 1.67% (day), 4.99% (last week), and 5.07% (last month), respectively.
Digital Ally's Stock Yearly Top and Bottom Value
Digital Ally's stock is valued at $0.55 at 16:22 EST, below its 52-week low of $0.55.
Digital Ally's Moving Average
Digital Ally's value is way below its 50-day moving average of $0.78 and way below its 200-day moving average of $1.00.4. Corcept Therapeutics Incorporated (CORT)
13.4% sales growth and 23.36% return on equity
Corcept Therapeutics Incorporated develops and markets drugs to treat severe metabolic and oncologic disorders. Korlym (mifepristone), a once daily oral medication, is offered to treat hyperglycemia secondary hypercortisolism among adult Cushing's patients. This treatment can be used for type 2 diabetes or other conditions that result in the need for insulin. The company is currently developing relacorilant for Cushing's patients; and nabpaclitaxel combined with relacorilant. Phase II clinical trials have been completed to treat serous ovarian cancers. Phase III clinical trials are underway to treat solid tumors. The company is also developing selective cortisol modulator combined with Xtandi that is in open label dose finding trial to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated is located in Menlo Park in California. It was established in 1998.
Corcept Therapeutics Incorporated's sales growth this year is anticipated to be 13.9% and 11.2% for next year.
Year-on-year quarterly revenue growth grew by 12.9%, now sitting on 392.03M for the twelve trailing months.
Volume
Today's last reported volume for Corcept Therapeutics Incorporated is 134382 which is 80.22% below its average volume of 679620.
Corcept Therapeutics Incorporated's sales growth is a negative 0% for the current quarter and 13.4% for the next. The company's growth estimates for the present quarter and the next is a negative 8.3% and negative -11.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.36%.
Volatility
Corcept Therapeutics Incorporated's last day, last week, and last month's current intraday variation average was 2.93%, 1.77%, and 1.81%, respectively.
Corcept Therapeutics Incorporated's highest amplitude of average volatility was 2.64% (day), 3.30% (last week), and 3.69% (last month), respectively.
Corcept Therapeutics Incorporated's Stock Yearly Top and Bottom Value
Corcept Therapeutics Incorporated's stock is valued at $26.09 at 16:22 EST, way below its 52-week high of $29.93 and way above its 52-week low of $15.83.
Corcept Therapeutics Incorporated's Moving Average
Corcept Therapeutics Incorporated's value is under its 50-day moving average of $26.67 and way higher than its 200-day moving average of $22.60.5. LendingClub Corporation (LC)
7.5% sales growth and 30.32% return on equity
LendingClub Corporation offers unsecured personal loans within the United States. The company operates an online platform for investors and borrowers. Marketplace offers a variety of loans for small and large businesses and consumers, such as auto refinance loans and education loans. Investors can also invest in various loans. It was established in 2006 in San Francisco, California.
LendingClub Corporation's sales growth this year is anticipated to be 46.5% and 12% for next year.
Year-on-year quarterly revenue growth grew by 51.8%, now sitting on 1.18B for the twelve trailing months.
Volume
Today's last reported volume for LendingClub Corporation is 1606310 which is 2.45% below its average volume of 1646670.
LendingClub Corporation's sales growth for the next quarter is 7.5%. The company's growth estimates for the current quarter and the next is 30.8% and 18.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 30.32%.
Volatility
LendingClub Corporation's last day, last week, and last month's current intraday variation average was 5.43%, 3.04%, and 2.68%, respectively.
LendingClub Corporation's highest amplitude of average volatility was 7.08% (day), 4.03% (last week), and 4.19% (last month), respectively.
LendingClub Corporation's Stock Yearly Top and Bottom Value
LendingClub Corporation's stock is valued at $13.82 at 16:22 EST, way under its 52-week high of $49.21 and way above its 52-week low of $11.16.